Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Novartis Pharmaceuticals Corporation
FDA Inspection
•Novartis Pharmaceuticals Corporation•June 25, 2025

Novartis Pharmaceuticals Corporation – FDA Inspection, Jun 25, 2025

Record Details

This FDA Inspection record concerns Novartis Pharmaceuticals Corporation, with an inspection on June 25, 2025, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Novartis Pharmaceuticals Corporation
Inspection Date
June 25, 2025
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Kellie R. Riggs (Company Rep)
  • Matthew R. Coleman (Issuing Officer)
View Company Profile

ID · d76eeb82-f498-4fa6-9c50-25c0625a0d59

Inspection Facts

No Action Indicated (NAI)

No objectionable conditions or practices were found during the inspection.

Inspection number
1276202
FDA center
Human Drugs
Project area
Bioresearch Monitoring

Other FDA inspections of Novartis Pharmaceuticals Corporation

30
DateClassificationOfficeProject area
June 24, 2026Not classifiedNew Jersey District Office
March 3, 2025Not classifiedNew Jersey District Office
November 19, 2024Not classifiedNew Jersey District Office
August 29, 2024NAICenter for Drug Evaluation and ResearchBioresearch Monitoring
June 27, 2024NAICenter for Drug Evaluation and ResearchBioresearch Monitoring
View all 30 other inspections on the company page
Other documents for Novartis Pharmaceuticals Corporation
  • FDA Inspection 1328008 - 2026-06-24
  • FDA Inspection 1263198 - 2025-03-03
  • FDA Inspection 1257911 - 2024-11-19
  • FDA Inspection 1248433 - 2024-08-29
  • FDA Inspection 1230105 - 2024-06-27

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Novartis Pharmaceuticals Corporation
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.